|
PNRC1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.81226170023774E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.2013950358496E-11 |
| Normal-vs-Stage2 |
1.4381995594448E-10 |
| Normal-vs-Stage3 |
3.08642000845794E-14 |
| Normal-vs-Stage4 |
1.80500059343558E-11 |
| Stage1-vs-Stage2 |
2.497400E-01 |
| Stage1-vs-Stage3 |
6.32010000000127E-05 |
| Stage1-vs-Stage4 |
1.509590E-01 |
| Stage2-vs-Stage3 |
2.067000E-01 |
| Stage2-vs-Stage4 |
8.616200E-01 |
| Stage3-vs-Stage4 |
2.082800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.63131746894396E-12 |
| Normal-vs-AfricanAmerican |
1.76779999999654E-05 |
| Normal-vs-Asian |
3.27820000034507E-08 |
| Caucasian-vs-AfricanAmerican |
2.992200E-01 |
| Caucasian-vs-Asian |
3.102300E-02 |
| AfricanAmerican-vs-Asian |
6.668400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.58040247555391E-11 |
| Normal-vs-Female |
4.22040180581007E-12 |
| Male-vs-Female |
6.912200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.32710550618754E-11 |
| Normal-vs-Age(41-60Yrs) |
6.58317844681733E-12 |
| Normal-vs-Age(61-80Yrs) |
2.25375273998907E-13 |
| Normal-vs-Age(81-100Yrs) |
4.616000E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.148000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.656400E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.313600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.377790E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.453800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.157600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.768000E-04 |
| Classical-VS-Follicular |
1.204760E-01 |
| Classical-VS-Other |
3.851200E-01 |
| Classical-VS-Normal |
7.54549756010192E-11 |
| Tall-VS-Follicular |
6.588000E-02 |
| Tall-VS-Other |
1.323360E-01 |
| Tall-VS-Normal |
3.46389583683049E-14 |
| Follicular-VS-Other |
2.389200E-01 |
| Follicular-VS-Normal |
9.37561139835452E-12 |
| Other-VS-Normal |
2.024400E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.95903318409319E-12 |
| Normal-vs-N1 |
6.07380812311931E-12 |
| N0-vs-N1 |
6.453400E-01 |
|
|
